Renaissance Technologies’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$269K Sell
8,600
-146,100
-94% -$4.57M ﹤0.01% 3076
2025
Q1
$5.19M Buy
154,700
+141,000
+1,029% +$4.73M 0.01% 1413
2024
Q4
$537K Sell
13,700
-30,300
-69% -$1.19M ﹤0.01% 2813
2024
Q3
$1.73M Sell
44,000
-48,900
-53% -$1.93M ﹤0.01% 2116
2024
Q2
$3.62M Buy
92,900
+36,500
+65% +$1.42M 0.01% 1508
2024
Q1
$2.43M Buy
56,400
+23,800
+73% +$1.02M ﹤0.01% 1902
2023
Q4
$1.5M Buy
32,600
+10,700
+49% +$493K ﹤0.01% 2134
2023
Q3
$748K Buy
+21,900
New +$748K ﹤0.01% 2489
2022
Q2
Sell
-150,777
Closed -$4.61M 4623
2022
Q1
$4.61M Sell
150,777
-230,100
-60% -$7.03M 0.01% 1659
2021
Q4
$11.9M Sell
380,877
-238,200
-38% -$7.44M 0.01% 986
2021
Q3
$9.46M Sell
619,077
-38,900
-6% -$594K 0.01% 1066
2021
Q2
$12.3M Sell
657,977
-35,000
-5% -$652K 0.02% 1034
2021
Q1
$12.4M Sell
692,977
-77,000
-10% -$1.38M 0.02% 1047
2020
Q4
$11.8M Sell
769,977
-133,300
-15% -$2.05M 0.01% 1050
2020
Q3
$10M Sell
903,277
-132,000
-13% -$1.46M 0.01% 1143
2020
Q2
$13M Buy
1,035,277
+247,200
+31% +$3.1M 0.01% 1068
2020
Q1
$8.94M Buy
788,077
+192,400
+32% +$2.18M 0.01% 1237
2019
Q4
$7.81M Buy
595,677
+107,077
+22% +$1.4M 0.01% 1600
2019
Q3
$4.4M Buy
488,600
+13,100
+3% +$118K ﹤0.01% 1867
2019
Q2
$4.69M Buy
475,500
+3,200
+0.7% +$31.5K ﹤0.01% 1852
2019
Q1
$4.8M Sell
472,300
-93,400
-17% -$949K ﹤0.01% 1837
2018
Q4
$3.57M Buy
565,700
+38,363
+7% +$242K ﹤0.01% 1943
2018
Q3
$6.96M Buy
527,337
+37,837
+8% +$499K 0.01% 1586
2018
Q2
$4.5M Buy
489,500
+201,500
+70% +$1.85M ﹤0.01% 1853
2018
Q1
$1.41M Buy
288,000
+39,000
+16% +$191K ﹤0.01% 2496
2017
Q4
$703K Buy
249,000
+92,600
+59% +$261K ﹤0.01% 2801
2017
Q3
$461K Buy
156,400
+26,100
+20% +$76.9K ﹤0.01% 2814
2017
Q2
$410K Sell
130,300
-86,790
-40% -$273K ﹤0.01% 2818
2017
Q1
$868K Buy
217,090
+102,890
+90% +$411K ﹤0.01% 2593
2016
Q4
$879K Buy
114,200
+18,000
+19% +$139K ﹤0.01% 2592
2016
Q3
$779K Buy
96,200
+47,700
+98% +$386K ﹤0.01% 2674
2016
Q2
$286K Buy
48,500
+14,700
+43% +$86.7K ﹤0.01% 2950
2016
Q1
$236K Sell
33,800
-5,305
-14% -$37K ﹤0.01% 3044
2015
Q4
$314K Buy
39,105
+18,605
+91% +$149K ﹤0.01% 2869
2015
Q3
$169K Sell
20,500
-21,500
-51% -$177K ﹤0.01% 2928
2015
Q2
$484K Buy
+42,000
New +$484K ﹤0.01% 2732